Clinical Trial Update: Transdermal Patch for BupRenorphine Induction DurinG PrEgnancy (Patch BRIDGE) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating a buprenorphine transdermal patch for induction during pregnancy in individuals with opioid use disorder; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• Buprenorphine transdermal patch (buprenorphine)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Opioid Use Disorder, Pregnancy Related | Phase 3 | Status: RECRUITING